A Los Angeles Times investigation alleges Purdue Pharma, the maker of OxyContin, continued supplying clinics and pharmacies it suspected of trafficking the highly addictive drug and never alerted law enforcement.
In one case, it continued supplying a single doctor clinic that, in just four months, prescribed 73,000 pills—which have a street value of more than $6 million.
To read more about the investigation, and why Purdue feels it was justified in not alerting federal agents, click on the link below:
John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.